According to expression of survivin, the 5-year survival rate of the NPC patients with survivin over-expression was 42.32% (n = 108), which was significantly lower than that in NPC patients with survivin low-expression (70.54%, n = 98, P = 0.0006; Figure 4A). Here, BIRC5 is linked to nasopharyngeal carcinoma.